| Kassie, Fekadu |
University Of Minnesota
United States |
Lung cancer prevention and treatment by targeting ALDH1 and CD44 expressing putative lung cancer stem cells |
5R01CA231210-05 |
Marjorie Perloff, M.D. |
| Kassie, Fekadu |
University Of Minnesota
United States |
Targeting tumor cell mitochondria for the prevention and treatment of lung cancer |
1R01CA285608-01A1 |
|
| Khan, Seema Ahsan |
Northwestern University At Chicago
United States |
Determinants of transdermal drug delivery to the normal and the radiated breast |
5R01CA235647-05 |
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Kim, Hyung L |
Cedars-Sinai Medical Center
United States |
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer |
5R01CA280060-02 |
Howard L. Parnes, M.D. |
| Kong, Mei |
University Of California-Irvine
United States |
Using dietary glutamine supplementation for melanoma prevention and targeted therapy |
5R01CA244360-05 |
Gabriela Riscuta, M.D., CNS |
| Kresty, Laura A |
University Of Michigan At Ann Arbor
United States |
Developing Natural Products to Target IL-8 Signaling and Intercept Progression of Barrett’s Esophagus to Esophageal Adenocarcinoma |
1UG3CA299397-01 |
Altaf Mohammed, Ph.D. |
| Kumar, Nagi B. |
H. Lee Moffitt Cancer Ctr & Res Inst
United States |
Phase II Clinical trial of GTC in Men on Active Surveillance |
5R01CA235032-06 |
Howard L. Parnes, M.D. |
| Langel, Stephanie N. |
Case Western Reserve University
United States |
Antibody bound bacteria during HPV infection and cervical dysplasia |
1R21CA289927-01 |
Goli Samimi, Ph.D., M.P.H. |
| Largaespada, David Andrew |
University Of Minnesota
United States |
Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention |
5UH3CA244687-05 |
|
| Leslie, Kimberly K. |
University Of New Mexico Health Scis Ctr
United States |
Advancing Hormone Therapy for Endometrial Cancer |
1P01CA278735-01A1 |
Goli Samimi, Ph.D., M.P.H. |
| Li, Yong |
Baylor College Of Medicine
United States |
DELINEATE THE TUMOR IMMUNE MICROENVIRONMENT FOR BETTER UNDERSTANDING IMMUNOTHERAPY RESPONSE |
3U54CA272691-02S1 |
Anda Vlad, M.D., Ph.D. |
| Li, Bing |
University Of Iowa
United States |
E-FABP mediates n-3 fatty acid-induced tumor prevention through epigenetic control of immune cell differentiation and function |
5R01CA180986-11 |
Nancy J. Emenaker, Ph.D., RDN, LD, FAND |
| Li, Chi |
University Of Louisville
United States |
A lung cancer vaccine based on exosomes of induced pluripotent stem cells |
1R21CA280453-01 |
John Clifford, Ph.D. |
| Lipkin, Steven M |
Weill Medical Coll Of Cornell Univ
United States |
CAP-IT Center for LNP RNA Immunoprevention |
5U54CA272688-03 |
John Clifford, Ph.D. |
| Lu, Junxuan |
Pennsylvania State Univ Hershey Med Ctr
United States |
Early clinial trials for Angelica herbal supplements for prostate cancer interception |
5R01CA260901-03 |
Gabriela Riscuta, M.D., CNS |
